(Q28192500)

https://api.crossref.org/works/10.1046/J.1365-2796.2002.00947.X

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.2002.00947.X

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Lower-limb arterial disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

The epidemiology of peripheral arterial disease: importance of identifying the population at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Vete

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Intermittent claudication. Incidence in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

The prevalence of peripheral arterial disease in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Ankle brachial index as a predictor of outcomes in peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Medical therapy of peripheral arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Antithrombotic therapy in peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Overview of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Fluid shear stress as a regulator of gene expression in vascular cells: possible correlations with diabetic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Antiplatelet therapy in atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Development of aspirin resistance in persons with previous ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Novel Antithrombotic Drugs in Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Reduction of requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: results from the Swedish Ticlopidine Multicentre Study (STIMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Clopidogrel and coronary stenting: what is the next question?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00947.X